ADL BioPharma’s offer includes a wide range of beta-lactamic APIs (both oral and sterile) either as part of our portfolio or contract manufactured. Moreover, ADL has the capacity to offer a solution to those customers that are in the process of developing high potency APIs.

In all cases, the manufacturing ensures cost-effectively GMP productions made under the highest quality standards, in strict compliance with FDA and EMA regulations.

Our current API manufacturing capacity:

Sterile Production Plant:

Up to 30 MT capacity for beta-lactamic antibiotics.

Semisynthetic Oral Plant:

1,000 MT capacity.

High Potency Plant:

50 m3 capacity for fermentation of high potency APIs.